Sermorelin at Home: The Growth Hormone Peptide Access Guide

Sermorelin is a growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary to produce more growth hormone. Compounded sermorelin is available through several men's health telehealth pathways. Here's what it is, what it does, and what the evidence actually supports.

What Sermorelin Is

Sermorelin is a synthetic peptide that mimics endogenous growth hormone-releasing hormone. Administered by subcutaneous injection, it prompts the pituitary gland to release more of the patient's own growth hormone. This differs from direct growth hormone (rHGH) therapy, which supplies exogenous GH directly.

The rationale for GHRH analogs over direct GH: potentially more physiologic release patterns, lower risk of pituitary desensitization, and simpler regulatory footing (GH itself is a controlled substance under specific conditions; GHRH analogs are not).

What the Evidence Actually Shows

Sermorelin was FDA-approved historically for growth hormone deficiency in children but was withdrawn from the commercial market years ago. Current use is exclusively via compounded formulations from 503A pharmacies. Evidence for outcome benefits in healthy adults (as opposed to children with confirmed GHRH deficiency) is limited and largely observational.

What's reasonably well-established: sermorelin raises IGF-1 levels in adults, which is a biomarker of growth hormone activity. What's less established: whether this biomarker change translates to meaningful outcomes in healthy adults — body composition, energy, sleep, or longevity endpoints.

How Home Delivery Works

Men's health telehealth platforms that offer sermorelin typically operate on the same model as compounded GLP-1s: intake via questionnaire, prescriber review, prescription sent to a compounding pharmacy, medication shipped to the patient. Dosing is typically nightly subcutaneous injection (to align with natural GH pulse patterns).

Who's Prescribing It

Sermorelin is generally prescribed for adults with symptoms consistent with adult growth hormone deficiency (fatigue, poor recovery, body composition changes) whose IGF-1 levels are in the low-normal range. Prescribers vary widely in how strict they are about labs and clinical criteria — some require confirmed IGF-1 deficits; others prescribe based on subjective symptoms.

The Honest Framing

Sermorelin is legal to prescribe via compounding, has a favorable safety profile at standard doses, and probably does raise IGF-1 in most patients who take it. Whether it delivers the anti-aging, recovery, and body composition benefits its marketing implies is less clear. Approach it as an experimental optimization tool with plausible mechanism, not a proven treatment. If you try it, track IGF-1 before and after, and evaluate honestly.

Where to Start